Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,792
Closed -$114K 342
2023
Q1
$114K Buy
2,792
+2,665
+2,098% +$115K 0.01% 105
2022
Q4
$7K Hold
127
﹤0.01% 229
2022
Q3
$6K Hold
127
﹤0.01% 228
2022
Q2
$7K Hold
127
﹤0.01% 249
2022
Q1
$7K Hold
127
﹤0.01% 216
2021
Q4
$7K Hold
127
﹤0.01% 337
2021
Q3
$5K Sell
127
-200
-61% -$8.86K ﹤0.01% 693
2021
Q2
$13K Sell
327
-905
-73% -$35.2K ﹤0.01% 529
2021
Q1
$45K Sell
1,232
-1,360
-52% -$48.3K ﹤0.01% 184
2020
Q4
$95K Buy
2,592
+2,381
+1,128% +$87.3K 0.01% 86
2020
Q3
$7K Sell
211
-71
-25% -$2.49K ﹤0.01% 151
2020
Q2
$9K Buy
282
+71
+34% +$2.41K ﹤0.01% 135
2020
Q1
$7K Hold
211
﹤0.01% 134
2019
Q4
$8K Sell
211
-1,073
-84% -$38.2K ﹤0.01% 161
2019
Q3
$44K Buy
+1,284
New +$46.7K 0.01% 97
2019
Q2
Sell
-1,308
Closed -$53K 252
2019
Q1
$53K Buy
1,308
+1,260
+2,625% +$50.5K 0.01% 76
2018
Q4
$2K Sell
48
-791
-94% -$32.8K ﹤0.01% 125
2018
Q3
$35K Hold
839
﹤0.01% 109
2018
Q2
$29K Buy
839
+417
+99% +$14.3K ﹤0.01% 65
2018
Q1
$14K Buy
422
+292
+225% +$10K ﹤0.01% 68
2017
Q4
$4K Buy
+130
New +$4.43K ﹤0.01% 71
2015
Q1
Sell
-12,653
Closed -$374K 69
2014
Q4
$374K Buy
+12,653
New +$363K 0.11% 68

Other funds holding PFE

Sageworth Trust's PFE Position: Q2 2023 in Review

Sageworth Trust sold out of Pfizer (PFE) in Q2 2023, closing a stake of 2,792 shares — an estimated $114K sold.

Sageworth Trust first reported a position in PFE in Q4 2014 and held it in 22 quarters. The position peaked at $374K in Q4 2014. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Sageworth Trust reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • Sageworth Trust sold 2,792 Pfizer shares in Q2 2023, an estimated $114K.
  • Sageworth Trust first reported a position in Pfizer in Q4 2014 and held it in 22 quarters.
  • Sageworth Trust's Pfizer position peaked at $374K in Q4 2014.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Sageworth Trust's 13F filing for Q2 2023, filed 26 Jul 2023.